Cargando…
Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer
Growing experience with engineered chimeric antigen receptor (CAR)‐T cells has revealed some of the challenges associated with developing patient‐specific therapy. The promising clinical results obtained with CAR‐T therapy nevertheless demonstrate the urgency of advancements to promote and expand it...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237845/ https://www.ncbi.nlm.nih.gov/pubmed/32440473 http://dx.doi.org/10.1002/advs.201903164 |